首页> 外文期刊>Drug delivery. >Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation
【24h】

Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation

机译:基于低分子量双酰胺有机胶凝剂的自组装给药系统:合成,性质和体内评价

获取原文
           

摘要

Abstract Context: Orgnaogels based on amino acid derivatives have been widely used in the area of drug delivery. Objective: An organogel system based on l -lysine derivatives was designed and prepared to induce a thermal sensitive implant with higher transition temperature, better mechanical strength, and shorter gelation time. Materials and methods: The organogel was prepared by injectable soybean oil and methyl (S)-2,5-ditetradecanamidopentanoate (MDP), which was synthesized for the first time. Candesartan cilexetil (CC) was chosen as model drug. Different formulations were designed and optimized by response surface method. Thermal, rheology properties, and gelation kinetics of the optimized formulation had been characterized. The release behaviors in vitro, as well as in vivo were evaluated in comparison with the oily solution of drugs. Finally, the local inflammation response of in situ organogel was assessed by histological analysis. Results and discussion: Results showed that the synthesized gelator, MDP, had a good gelation ability and the organogels obtained via the self-assembly of gelators in vegetable oils exhibited great thermal and rheology properties, which guaranteed their state in body. In vivo pharmacokinetic demonstrated that the organogel formulation could extend the drug release and maintain a therapeutically effective plasma concentration at least 10 d. In addition, this implant showed acceptable moderate inflammation. Conclusion: The in situ forming l -lysine-derivative-based organogel could be a promising matrix for sustained drug delivery of the drugs with low solubility.
机译:摘要背景:基于氨基酸衍生物的Orgnaogels已被广泛用于药物输送领域。目的:设计并制备了基于1-赖氨酸衍生物的有机凝胶体系,以诱导具有更高的转变温度,更好的机械强度和更短的胶凝时间的热敏植入物。材料和方法:该有机凝胶是通过注射大豆油和首次合成的(S)-2,5-ditetradecanamidodopentanoate甲酯(MDP)制备的。选择Candesartan cilexetil(CC)作为模型药物。通过响应面法设计和优化了不同的配方。表征了优化配方的热,流变性质和胶凝动力学。与药物的油性溶液相比,评估了体外和体内的释放行为。最后,通过组织学分析评估原位有机凝胶的局部炎症反应。结果与讨论:结果表明,合成的MDP胶凝剂具有良好的胶凝能力,通过植物油中的胶凝剂自组装获得的有机凝胶具有良好的热和流变性能,从而保证了它们在体内的状态。体内药代动力学证明,有机凝胶制剂可延长药物释放并维持至少10 d的治疗有效血浆浓度。另外,该植入物显示出可接受的中度炎症。结论:原位形成的基于l-赖氨酸衍生物的有机凝胶可能是低溶解度药物持续给药的有希望的基质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号